A 50 kdyne contusion spinal cord injury with or without the drug SS-31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice
Open Access
- 1 February 2021
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 9 (4), e14751
- https://doi.org/10.14814/phy2.14751
Abstract
Spinal cord injury (SCI) leads to rapid muscle atrophy due to paralysis/paresis and subsequent disuse. SS-31 is a mitochondrial-targeting peptide that has shown efficacy in protecting skeletal muscle mass and function in non-SCI models of muscle wasting. We aimed to determine if SS-31 could prevent muscle loss after SCI. Male C57BL/6 mice aged 9 weeks underwent sham surgery or 50 kdyne contusion SCI and were administered daily injections of vehicle or 5 mg/kg SS-31 for 14 d. Both SCI groups had sustained losses in body mass compared to Sham animals and similar to 10% reductions in gastrocnemius, plantaris and tibialis anterior muscle mass after SCI with no clear effect of SS-31. Measurements of protein synthesis in the soleus and plantaris were similar among all groups. mRNA expression of atrophy-associated proinflammatory cytokines was also similar among all groups. There was elevation in MYH7 mRNA and a statistical reduction in MYH2 mRNA expression in the SCI+SS-31 animals compared to Sham animals. There was an SCI-induced reduction in mRNA expression of the E3 ligase FBXO32 (MAFbx), but no effect of SS-31. In summary, a 50 kdyne contusion SCI was able to reduce body mass but was not associated with substantial muscle atrophy or alterations in gene expression profiles associated with muscle health and function 14 d post-injury. SS-31 was not associated with protection against SCI-related changes in body or muscle mass, protein synthesis or gene expression in hindlimb muscles.Funding Information
- U.S. Department of Veterans Affairs (IK2RX002781, IK50RX02020)
This publication has 60 references indexed in Scilit:
- Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged miceAging Cell, 2013
- Mechanisms regulating skeletal muscle growth and atrophyThe FEBS Journal, 2013
- Novel Mitochondria-Targeted Antioxidant Peptide Ameliorates Burn-Induced Apoptosis and Endoplasmic Reticulum Stress in the Skeletal Muscle of MiceShock, 2011
- Mitochondrial-targeted antioxidants protect skeletal muscle against immobilization-induced muscle atrophyJournal of Applied Physiology, 2011
- FIBER TYPES IN MAMMALIAN SKELETAL MUSCLESPhysiological Reviews, 2011
- Ryanodine Receptor Oxidation Causes Intracellular Calcium Leak and Muscle Weakness in AgingCell Metabolism, 2011
- Acute Management of Nutritional Demands after Spinal Cord InjuryJournal of Neurotrauma, 2011
- Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactivein vivotechniqueThe FASEB Journal, 2010
- Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscleNature Medicine, 2009
- Denervation Induces Cytosolic Phospholipase A2-mediated Fatty Acid Hydroperoxide Generation by Muscle MitochondriaOnline Journal of Public Health Informatics, 2009